INDEGENE
Back to Cashflow Statement
|
INDEGENE Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-66 Cr | ₹333 Cr | ₹233 Cr | ₹-132 Cr | ₹136 Cr |
What is the latest Cash Flow from Financing Activities ratio of INDEGENE ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-66 Cr |
Mar2023 | ₹333 Cr |
Mar2022 | ₹233 Cr |
Mar2021 | ₹-132 Cr |
Mar2020 | ₹136 Cr |
How is Cash Flow from Financing Activities of INDEGENE Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-66 Cr | Negative | |
Mar2023 | ₹333 Cr | 42.67 | |
Mar2022 | ₹233 Cr | Positive | |
Mar2021 | ₹-132 Cr | Negative | |
Mar2020 | ₹136 Cr | - |
Compare Cash Flow from Financing Activities of peers of INDEGENE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INDEGENE | ₹13,346.4 Cr | -3.8% | 5.3% | NA | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹410,142.0 Cr | -1.5% | 9.1% | 9.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹145,762.0 Cr | -4.9% | -0.6% | 59.1% | Stock Analytics | |
CIPLA | ₹114,322.0 Cr | -1.8% | 1% | 0.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹111,171.0 Cr | 1.6% | 12.1% | 21.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹92,603.7 Cr | -3% | -0.9% | -7.7% | Stock Analytics |
INDEGENE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDEGENE | -3.8% |
5.3% |
|
SENSEX | -2.9% |
3.1% |
1.8% |
You may also like the below Video Courses